Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations
- Autores
- Sánchez Maslovski, Franco Martín; Alonso, Maria del Rosario; López, Gisela Lumila; Leiva, Laura Cristina Ana; Fusco, Luciano Sebastian
- Año de publicación
- 2024
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- Different aspects determine the choice of an adjuvant to generate optimal antibody productionwhile ensuring the safety of the producing animal. In this context, ASC16 that can form safehydrogels or act as a toxin inhibitor depending on whether it is present at high or low concentrations, respectively. For these reasons, it was proposed to evaluate the effect of dispersed ASC16 (low concentration) as an additive adjuvant in the production of experimental antivenom. BALB/c mice were immunised with Freund’s adjuvant in the presence or absence of additive (AFMo and AF) and hydrogel with or without additive (Pa40Mo and Pa40). Afterwards, ELISA, avidity andimmunoblotting tests were performed to determine the titre, binding strength and specificity ofthe antibodies. Finally, we determine the effective dose 50 (ED50) that neutralises PLA2 activityof Crotalus durissus terrificus venom. We used the t-tests for two independent samples to verifyif there were significant differences. Our results show that AFMo induced the highest titres (4.07),followed by AF and Pa40Mo (both 3.75), although without significant differences (p>0.05), and finally Pa40 (3.27). Notably, the additive ASC16 also improved antibody avidity, with AFMo (4.35 MKSCN) standing out with significant differences compared to the rest (p≤0.05), followed by AFand Pa40Mo (3.21 and 3.17 M KSCN) with no significant differences (p>0.05), and finally Pa40(1.61 M KSCN). In addition, the antibodies recognised the main antigenic components of thevenom. The sera produced by formulations with additive presented a better ED50 for PLA2 activity, highlighting Pa40Mo (7.04 µL), followed by AFMo (9.02 µL) with significant differences (p≤0.05) compared to Pa40 (12.20 µL) and AF (12.23 µL). This study shows that formulationswith additive ASC16 as an enhancer induce higher antibody titres, improve avidity, have a greaterspecificity and neutralising effect on PLA2 activity than formulations without the additive.
Fil: Sánchez Maslovski, Franco Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina
Fil: Alonso, Maria del Rosario. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina
Fil: López, Gisela Lumila. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina
Fil: Leiva, Laura Cristina Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina
Fil: Fusco, Luciano Sebastian. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina
14th Latin American and Caribbean Congress of Immunology
Buenos aires
Argentina
Sociedad Argentina de Inmunología
Latin America and Caribbean Association of Immunology
Asociación de Inmunólogos Clínicos de Argentina - Materia
-
ASC16
ADJUVANT
ADDITIVE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/275566
Ver los metadatos del registro completo
| id |
CONICETDig_4f0ec656eae49685139b4e4160801d95 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/275566 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulationsSánchez Maslovski, Franco MartínAlonso, Maria del RosarioLópez, Gisela LumilaLeiva, Laura Cristina AnaFusco, Luciano SebastianASC16ADJUVANTADDITIVEhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Different aspects determine the choice of an adjuvant to generate optimal antibody productionwhile ensuring the safety of the producing animal. In this context, ASC16 that can form safehydrogels or act as a toxin inhibitor depending on whether it is present at high or low concentrations, respectively. For these reasons, it was proposed to evaluate the effect of dispersed ASC16 (low concentration) as an additive adjuvant in the production of experimental antivenom. BALB/c mice were immunised with Freund’s adjuvant in the presence or absence of additive (AFMo and AF) and hydrogel with or without additive (Pa40Mo and Pa40). Afterwards, ELISA, avidity andimmunoblotting tests were performed to determine the titre, binding strength and specificity ofthe antibodies. Finally, we determine the effective dose 50 (ED50) that neutralises PLA2 activityof Crotalus durissus terrificus venom. We used the t-tests for two independent samples to verifyif there were significant differences. Our results show that AFMo induced the highest titres (4.07),followed by AF and Pa40Mo (both 3.75), although without significant differences (p>0.05), and finally Pa40 (3.27). Notably, the additive ASC16 also improved antibody avidity, with AFMo (4.35 MKSCN) standing out with significant differences compared to the rest (p≤0.05), followed by AFand Pa40Mo (3.21 and 3.17 M KSCN) with no significant differences (p>0.05), and finally Pa40(1.61 M KSCN). In addition, the antibodies recognised the main antigenic components of thevenom. The sera produced by formulations with additive presented a better ED50 for PLA2 activity, highlighting Pa40Mo (7.04 µL), followed by AFMo (9.02 µL) with significant differences (p≤0.05) compared to Pa40 (12.20 µL) and AF (12.23 µL). This study shows that formulationswith additive ASC16 as an enhancer induce higher antibody titres, improve avidity, have a greaterspecificity and neutralising effect on PLA2 activity than formulations without the additive.Fil: Sánchez Maslovski, Franco Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; ArgentinaFil: Alonso, Maria del Rosario. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; ArgentinaFil: López, Gisela Lumila. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; ArgentinaFil: Leiva, Laura Cristina Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; ArgentinaFil: Fusco, Luciano Sebastian. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina14th Latin American and Caribbean Congress of ImmunologyBuenos airesArgentinaSociedad Argentina de InmunologíaLatin America and Caribbean Association of ImmunologyAsociación de Inmunólogos Clínicos de ArgentinaSociedad Argentina de Inmunología2024info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectCongresoBookhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/275566Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations; 14th Latin American and Caribbean Congress of Immunology; Buenos aires; Argentina; 2024; 356-356978-950-34-2435-3CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://sedici.unlp.edu.ar/handle/10915/173621info:eu-repo/semantics/altIdentifier/doi/10.35537/10915/173621Internacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-12-03T09:46:18Zoai:ri.conicet.gov.ar:11336/275566instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-12-03 09:46:19.123CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations |
| title |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations |
| spellingShingle |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations Sánchez Maslovski, Franco Martín ASC16 ADJUVANT ADDITIVE |
| title_short |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations |
| title_full |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations |
| title_fullStr |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations |
| title_full_unstemmed |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations |
| title_sort |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations |
| dc.creator.none.fl_str_mv |
Sánchez Maslovski, Franco Martín Alonso, Maria del Rosario López, Gisela Lumila Leiva, Laura Cristina Ana Fusco, Luciano Sebastian |
| author |
Sánchez Maslovski, Franco Martín |
| author_facet |
Sánchez Maslovski, Franco Martín Alonso, Maria del Rosario López, Gisela Lumila Leiva, Laura Cristina Ana Fusco, Luciano Sebastian |
| author_role |
author |
| author2 |
Alonso, Maria del Rosario López, Gisela Lumila Leiva, Laura Cristina Ana Fusco, Luciano Sebastian |
| author2_role |
author author author author |
| dc.subject.none.fl_str_mv |
ASC16 ADJUVANT ADDITIVE |
| topic |
ASC16 ADJUVANT ADDITIVE |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
| dc.description.none.fl_txt_mv |
Different aspects determine the choice of an adjuvant to generate optimal antibody productionwhile ensuring the safety of the producing animal. In this context, ASC16 that can form safehydrogels or act as a toxin inhibitor depending on whether it is present at high or low concentrations, respectively. For these reasons, it was proposed to evaluate the effect of dispersed ASC16 (low concentration) as an additive adjuvant in the production of experimental antivenom. BALB/c mice were immunised with Freund’s adjuvant in the presence or absence of additive (AFMo and AF) and hydrogel with or without additive (Pa40Mo and Pa40). Afterwards, ELISA, avidity andimmunoblotting tests were performed to determine the titre, binding strength and specificity ofthe antibodies. Finally, we determine the effective dose 50 (ED50) that neutralises PLA2 activityof Crotalus durissus terrificus venom. We used the t-tests for two independent samples to verifyif there were significant differences. Our results show that AFMo induced the highest titres (4.07),followed by AF and Pa40Mo (both 3.75), although without significant differences (p>0.05), and finally Pa40 (3.27). Notably, the additive ASC16 also improved antibody avidity, with AFMo (4.35 MKSCN) standing out with significant differences compared to the rest (p≤0.05), followed by AFand Pa40Mo (3.21 and 3.17 M KSCN) with no significant differences (p>0.05), and finally Pa40(1.61 M KSCN). In addition, the antibodies recognised the main antigenic components of thevenom. The sera produced by formulations with additive presented a better ED50 for PLA2 activity, highlighting Pa40Mo (7.04 µL), followed by AFMo (9.02 µL) with significant differences (p≤0.05) compared to Pa40 (12.20 µL) and AF (12.23 µL). This study shows that formulationswith additive ASC16 as an enhancer induce higher antibody titres, improve avidity, have a greaterspecificity and neutralising effect on PLA2 activity than formulations without the additive. Fil: Sánchez Maslovski, Franco Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina Fil: Alonso, Maria del Rosario. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina Fil: López, Gisela Lumila. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina Fil: Leiva, Laura Cristina Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina Fil: Fusco, Luciano Sebastian. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste. Instituto de Química Básica y Aplicada del Nordeste Argentino. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas Naturales y Agrimensura. Instituto de Química Básica y Aplicada del Nordeste Argentino; Argentina 14th Latin American and Caribbean Congress of Immunology Buenos aires Argentina Sociedad Argentina de Inmunología Latin America and Caribbean Association of Immunology Asociación de Inmunólogos Clínicos de Argentina |
| description |
Different aspects determine the choice of an adjuvant to generate optimal antibody productionwhile ensuring the safety of the producing animal. In this context, ASC16 that can form safehydrogels or act as a toxin inhibitor depending on whether it is present at high or low concentrations, respectively. For these reasons, it was proposed to evaluate the effect of dispersed ASC16 (low concentration) as an additive adjuvant in the production of experimental antivenom. BALB/c mice were immunised with Freund’s adjuvant in the presence or absence of additive (AFMo and AF) and hydrogel with or without additive (Pa40Mo and Pa40). Afterwards, ELISA, avidity andimmunoblotting tests were performed to determine the titre, binding strength and specificity ofthe antibodies. Finally, we determine the effective dose 50 (ED50) that neutralises PLA2 activityof Crotalus durissus terrificus venom. We used the t-tests for two independent samples to verifyif there were significant differences. Our results show that AFMo induced the highest titres (4.07),followed by AF and Pa40Mo (both 3.75), although without significant differences (p>0.05), and finally Pa40 (3.27). Notably, the additive ASC16 also improved antibody avidity, with AFMo (4.35 MKSCN) standing out with significant differences compared to the rest (p≤0.05), followed by AFand Pa40Mo (3.21 and 3.17 M KSCN) with no significant differences (p>0.05), and finally Pa40(1.61 M KSCN). In addition, the antibodies recognised the main antigenic components of thevenom. The sera produced by formulations with additive presented a better ED50 for PLA2 activity, highlighting Pa40Mo (7.04 µL), followed by AFMo (9.02 µL) with significant differences (p≤0.05) compared to Pa40 (12.20 µL) and AF (12.23 µL). This study shows that formulationswith additive ASC16 as an enhancer induce higher antibody titres, improve avidity, have a greaterspecificity and neutralising effect on PLA2 activity than formulations without the additive. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Congreso Book http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
| status_str |
publishedVersion |
| format |
conferenceObject |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/275566 Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations; 14th Latin American and Caribbean Congress of Immunology; Buenos aires; Argentina; 2024; 356-356 978-950-34-2435-3 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/275566 |
| identifier_str_mv |
Dispersed Ascorbyl palmitate (ASC16) as an additive in adjuvant formulations; 14th Latin American and Caribbean Congress of Immunology; Buenos aires; Argentina; 2024; 356-356 978-950-34-2435-3 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://sedici.unlp.edu.ar/handle/10915/173621 info:eu-repo/semantics/altIdentifier/doi/10.35537/10915/173621 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
| dc.coverage.none.fl_str_mv |
Internacional |
| dc.publisher.none.fl_str_mv |
Sociedad Argentina de Inmunología |
| publisher.none.fl_str_mv |
Sociedad Argentina de Inmunología |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1850505898183622656 |
| score |
13.275514 |